Advertisement

Topics

Nicox Receives FDA Approval of Zerviate (cetirizine ophthalmic solution) 0.24%

17:05 EDT 31 May 2017 | Drugs.com

Sophia Antipolis, France, May 31, 2017 -- Nicox S.A. (Euronext Paris: FR0013018124, COX), the international ophthalmic R&D company, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for...

Original Article: Nicox Receives FDA Approval of Zerviate (cetirizine ophthalmic solution) 0.24%

NEXT ARTICLE

More From BioPortfolio on "Nicox Receives FDA Approval of Zerviate (cetirizine ophthalmic solution) 0.24%"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...